Periscope Capital’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-200,000
| Closed | -$44K | – | 517 |
|
|
2023
Q3 | $44K | Sell |
200,000
-209,800
| -51% | -$46.2K | 0.01% | 376 |
|
|
2023
Q2 | $49.4K | Hold |
409,800
| – | – | ﹤0.01% | 423 |
|
|
2023
Q1 | $19.7K | Hold |
409,800
| – | – | ﹤0.01% | 659 |
|
|
2022
Q4 | $18.8K | Buy |
409,800
+122,400
| +43% | +$5.61K | ﹤0.01% | 692 |
|
|
2022
Q3 | $16K | Hold |
287,400
| – | – | ﹤0.01% | 924 |
|
|
2022
Q2 | $26K | Hold |
287,400
| – | – | ﹤0.01% | 864 |
|
|
2022
Q1 | $103K | Hold |
287,400
| – | – | ﹤0.01% | 754 |
|
|
2021
Q4 | $144K | Buy |
+287,400
| New | +$144K | ﹤0.01% | 755 |
|